Wang YC - Search Results

1

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer.

Hsu HS, Wen CK, Tang YA, Lin RK, Li WY, Hsu WH, Wang YC. Hsu HS, et al. Among authors: wang yc. Clin Cancer Res. 2005 Aug 1;11(15):5410-6. doi: 10.1158/1078-0432.CCR-05-0601. Clin Cancer Res. 2005. PMID: 16061855

2

High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.

Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H. Wang YC, et al. Cancer Res. 1998 Jan 15;58(2):328-33. Cancer Res. 1998. PMID: 9443413

3

p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.

Wang YC, Chen CY, Chen SK, Chang YY, Lin P. Wang YC, et al. Clin Cancer Res. 1999 Jan;5(1):129-34. Clin Cancer Res. 1999. PMID: 9918210

4

Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.

Shih CM, Lin PT, Wang HC, Huang WC, Wang YC. Shih CM, et al. Among authors: wang hc, wang yc. Jpn J Cancer Res. 2000 Jan;91(1):9-15. doi: 10.1111/j.1349-7006.2000.tb00854.x. Jpn J Cancer Res. 2000. PMID: 10744039 Free PMC article.

5

Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer.

Chang JW, Chen YC, Chen CY, Chen JT, Chen SK, Wang YC. Chang JW, et al. Among authors: wang yc. Clin Cancer Res. 2000 May;6(5):1639-46. Clin Cancer Res. 2000. PMID: 10815881

6

Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.

Chen JT, Chen YC, Chen CY, Wang YC. Chen JT, et al. Among authors: wang yc. Lung Cancer. 2001 Feb-Mar;31(2-3):163-70. doi: 10.1016/s0169-5002(00)00191-4. Lung Cancer. 2001. PMID: 11165395

7

Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum.

Chen JT, Chen YC, Wang YC, Tseng RC, Chen CY, Wang YC. Chen JT, et al. Among authors: wang yc. Int J Cancer. 2002 Apr 10;98(5):724-31. doi: 10.1002/ijc.10262. Int J Cancer. 2002. PMID: 11920642

8

Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.

Shih CM, Kuo YY, Wang YC, Jian SL, Hsu YT, Wu HY, Guo MW, Wang YC. Shih CM, et al. Among authors: wang yc. Lung Cancer. 2002 May;36(2):125-32. doi: 10.1016/s0169-5002(01)00467-6. Lung Cancer. 2002. PMID: 11955646

9

Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer.

Ho WL, Chang JW, Tseng RC, Chen JT, Chen CY, Jou YS, Wang YC. Ho WL, et al. Among authors: wang yc. Cancer Detect Prev. 2002;26(5):343-9. doi: 10.1016/s0361-090x(02)00088-0. Cancer Detect Prev. 2002. PMID: 12518864

10

Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.

Wang YC, Lu YP, Tseng RC, Lin RK, Chang JW, Chen JT, Shih CM, Chen CY. Wang YC, et al. J Clin Invest. 2003 Mar;111(6):887-95. doi: 10.1172/JCI15475. J Clin Invest. 2003. PMID: 12639995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,595 results

Search Page

Filters